Search results
What Is The New Treatment Instead of Chemotherapy?
San Diego Red via Yahoo News· 7 days agoAmerica has qualified medical personnel to walk you through your cancer journey, but the prices are out-of-this-world. It’s extremely difficult to find...
Autolus Therapeutics (NASDAQ:AUTL) Releases Earnings Results, Misses Expectations By $0.14 EPS
ETF DAILY NEWS· 1 day agoAutolus Therapeutics (NASDAQ:AUTL – Get Free Report) posted its earnings results on Friday. The company reported ($0.24) earnings per share (EPS) for the quarter, missing analysts’ consensus ...
Bristol Myers (BMY) Gets FDA Nod for Breyanzi Label Expansion
Zacks via Yahoo Finance· 5 days agoBristol Myers Squibb (BMY) obtains FDA approval for the label expansion of CAR T cell therapy...
Cancer death rates are dropping, but not for everyone
AOL· 6 days agoA new report out from the American Association for Cancer Research highlights the overall cancer...
Dodgers milestones: 5 players reflect on 10 years of big-league service
New York Times· 4 days agoAfter a breezy, if unspectacular win over the Minnesota Twins last month, the Los Angeles Dodgers...
Needham & Company LLC Reaffirms Buy Rating for Autolus Therapeutics (NASDAQ:AUTL)
ETF DAILY NEWS· 1 day agoNeedham & Company LLC reaffirmed their buy rating on shares of Autolus Therapeutics (NASDAQ:AUTL – Free Report) in a research note released on Friday, Benzinga reports. They currently have a ...
A world without cancer: We can get there from here
Miami Herald via Yahoo News· 2 days agoWhile cancer deaths overall are in decline, more people are getting certain cancers, and people of color, in particular, suffer a disproportionate...
Report shows disparities in cancer outcomes based on race, location, sexuality
United Press International via Yahoo News· 6 days agoRace, location and sexuality all play a role in cancer disparities across the United States,...
What Can I Do To Prevent Spondylolisthesis From Getting Worse? A Review By Doctors
MSN News· 7 days agoExpert opinion from Gustavo Campos Doctor of Medicine · 9 years of experience · Brazil It's...
These 2 No-Brainer Growth Stocks Are Breaking New Ground | The Motley Fool
The Motley Fool· 5 days agoEli Lilly (LLY -2.02%) and Regeneron Pharmaceuticals (REGN -1.05%) have historically been in the...